Showing 5941-5950 of 8887 results for "".
- DERMWIRE Exclusive: FDA Clears Cutera’s AviClear Acne Devicehttps://practicaldermatology.com/news/dermwire-exclusive-fda-clears-cuteras-aviclear-acne-device/2461124/The U.S. Food and Drug Administration has cleared granted 510(k) clearance to Cutera’s AviClear acne device. This is the first energy device to receive a nod for the treatment of mild, moderate, and severe acne. AviClear targets acne at the source by selec
- Project IMPACT from VisualDx Marks One Yearhttps://practicaldermatology.com/news/project-impact-from-visualdx-marks-one-year-1/2461123/VisualDx marks the one-year anniversary of
- Jeune Aesthetics Announces Positive Clinical Phase 1 Efficacy Results for KB301https://practicaldermatology.com/news/jeune-aesthetics-announces-positive-clinical-phase-1-efficacy-results-for-kb301/2461119/Aesthetics, Inc.’s KB301 demonstrated promise in proof-of-concept in the Phase 1 PEARL-1 study. Specifically, Cohort 2 of this trial evaluated KB301 for the improvement of fine lines and skin texture in the lower and upper cheek, and for improvement in skin thickness in
- DefenAge Receives Two US Patents For Melasma and Hair Growthhttps://practicaldermatology.com/news/defenage-receives-two-us-patents-for-melasma-and-hair-growth/2461118/The US Patent and Trademark Office has granted two new patents to Defanage Skincare for the use of Defensin-molecules for topical treatment of hair loss in skin affected by alopecia and of the hyperpigmented lesions of melasma: &l
- Evommune Initiates Phase 1 Study of EVO101 for Inflammatory Skin Diseaseshttps://practicaldermatology.com/news/evommune-initiates-phase-1-study-of-evo101-for-inflammatory-skin-diseases/2461117/Evommune, Inc. has enrolled the first participant in its Phase 1 study of EVO101 in healthy volunteers. EVO101 is a novel small molecule inhibitor of interleukin 1 receptor-associated kinase 4 (IRAK4) which broadly inhibits innate inflammation and is being
- Dove, Crown Coalition Applaud U.S. House of Representatives for Passing Crown Acthttps://practicaldermatology.com/news/dove-crown-coalition-applaud-us-house-of-representatives-for-passing-crown-act/2461116/The CROWN Coalition, a national alliance founded by Dove, National Urban League, Western Center on Law & Poverty and Color of Change, along with more than 90 members of the CROWN Coalition praise the U.S. House of Representatives for passing the CROWN A
- Mount Sinai Health System Launches Alopecia Areata Center of Excellencehttps://practicaldermatology.com/news/mount-sinai-health-system-launches-alopecia-areata-center-of-excellence/2461115/In an effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics around the skin condition alopecia areata, the Mount Sinai Health System has launched the Alopecia Areata Center of Excellence. Under the leadership of Director Emma Guttman-Yassky,
- Cynosure Partners with Jeisys Medical Japanhttps://practicaldermatology.com/news/cynosure-partners-with-jeisys-medical-japan/2461114/Cynosure LLC’s subsidiary Cynosure KK has entered into a distribution partnership with Jeisys Medical KK, a subsidiary of Jeisys Medical Inc. in Japan. Under the terms of the agreement, Jeisys Medical will have exclusive distribution rights for products within Cynosure&
- Study: Laser Surgery Lawsuits Less Likely with Physician Operatorshttps://practicaldermatology.com/news/study-laser-surgery-lawsuits-less-likely-with-physician-operators/2461113/The majority of liability claims due to a cutaneous laser surgery device between 2012 and 2020 involved a non-physician operator, according to a new study in the March 2022 issue of Dermatologic Surgery. Researchers analyzed cases of liability claims due to a cutaneou
- Residents of Distinction Recognized at Maui Dermhttps://practicaldermatology.com/news/residents-of-distinction-honored-at-maui-derm/2461111/Sydney Liang, MD, a second-year resident at New York University, was awarded the Overall Grand Prize and was one of five dermatology residents recognized by DermMentors™ as part of the 11th Annual dermMentors™ Resident of Distinction Award™ for 2022.